Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Fatty acid binding protein 5 pseudogene 5 (FABP5P5), also known as FABP5L5 or fatty acid binding protein 5-like 5, is annotated as a pseudogene in genomic databases and scientific nomenclature. Pseudogenes are non-functional genomic DNA sequences that resemble normal genes but typically lack the capacity to encode a functional protein due to mutations, truncations, or lack of regulatory elements. FABP5P5 is related by sequence to the functional fatty acid binding protein 5 (FABP5) gene, but it does not produce a functional protein product and has no established role as a therapeutic target, biomarker, or drug interaction partner. There is no evidence that it is functionally involved in metabolism, signaling, or disease processes. The entry is often reported due to sequence similarity with FABP5, but should not be mistaken for the active protein-coding gene or its biological roles[1][2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Fatty acid binding protein 5 pseudogene 5 (FABP5P5).